While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Investigators compared outcomes among patients with psoriasis undergoing apremilast treatment with genital involvement versus those without genital involvement.

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

The researchers found that several types of blood pressure medications—especially ACE inhibitors, beta-blockers, ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While ...

Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase ...

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...

When psoriasis develops on your feet, it can cause uncomfortable itching or soreness that makes tasks like walking difficult. Psoriasis, an autoimmune skin condition, usually causes scaly rashes ...

Post-hoc analyses of the EFFISAYIL 2 trial revealed improvements in Psoriasis Symptom Scale (PSS), Pain Visual Analog Scale ...